Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial
雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌患者的患者报告结局和定性访谈：来自III期EMBER-3试验的结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106945
Curigliano, G; O'Shaughnessy, J; Bidard, F-C; Casalnuovo, M L; Kim, S-B; Tokunaga, E; Aftimos, P; Saura, C; Carey, L A; Okera, M; Melo, E; Zagouri, F; Magallanes-Maciel, M; Karadurmus, N; Bahadur, S; Speck, R M; Wang, X A; Pradhan, K; Macey, J; Kitchen, H; Fairhurst, S; Miller, J; Jhaveri, K L; Harbeck, N
